近日,发表于《Drug Design, Development and Therapy》期刊的研究‘Resveratrol Protects Osteoblasts Against Dexamethasone-Induced Cytotoxicity Through Activation of AMP-Activated Protein Kinase’因数据问题引发质疑。该研究由Liang Wang , Qiushi Li , Haibo Yan , Guangjun Jiao , Hongliang Wang , Hai Chi , Hongming Zhou , Lu Chen , Yu Shan , Yunzhen Chen(通讯作者,原脊柱外科主任)共同完成,通讯单位为山东大学齐鲁医院骨科。